This study was supported by the National Heart, Lung, and Blood Institute (NHLBI) (HL169522).

The details of all the reagents and equipment used for the study are listed in the Table of Materials.
1. Plate reading spectrophotometer high-throughput assay
<ol>
	<li>Seeding HEK-293 cells with the cADDis BacMam vector in a 96-well plate (Day 1)
	<ol>
		<li>Split and infect cells in a viral hood.
		<ol>
			<li>Warm HEK media (Table 1) and 0.25% trypsin-EDTA in a 37 &#176;C water bath.</li>
			<li>Disinfect the hood and the materials by wiping them with EtOH-soaked tissues.</li>
			<li>Remove and discard HEK media from the flask with a serological pipette.</li>
			<li>Add 5 mL of Mg2+ and Ca2+ free DPBS (37 &#176;C) with a serological pipette. Tilt the flask back and forth to wash the bottom with DPBS. Remove and discard DPBS with a serological pipette.</li>
			<li>Trypsinize the cells by adding 3 mL of warmed 0.25% trypsin-EDTA with a serological pipette. Tilt the flask to ensure the reagent fully coats the bottom of the flask. Put the lid on the flask and let the reagent sit for 3-5 min to allow the cells to detach from the&#160;flask. 
			NOTE: This experiment is optimized for a 75 cm2 flask; volume adjustments for reagents may need to be made if a different-size culture apparatus is used.</li>
			<li>Draw 5 mL of fresh media containing antibiotics. Expel and draw the volume of the flask to wash the walls of the flask and physically detach cells.</li>
			<li>Collect the total volume of the flask (8 mL), and centrifuge (25 &#176;C) in a 15 mL tube at 200 x g for 5 min.</li>
			<li>After centrifuging, remove the supernatant with a serological pipette, careful not to disturb the pellet.</li>
			<li>To wash the cells without disturbing the pellet, add 500 &#181;L of DPBS without Mg2+ and Ca2+ DPBS to the side of the 15 mL tube. After gently adding the DPBS, remove and discard as much buffer as possible without disturbing the pellet. Repeat one&#160;more time.</li>
			<li>Count the cells and adjust to a cell density of 250,000 cells/mL cells.</li>
			<li>Make a master mix based on what reagent volumes are needed per well of a black, transparent bottom 96-well plate. This is referred to as the &#34;tissue plate.&#34; See volumes below: 
			NOTE: Example of 1 well (total volume 200 &#181;L): 40 &#181;L of the biosensor BacMam vector (stock of 2 x 1010 viral genes /mL), 2 &#181;L trichostatin A (stock of 100 &#181;M; final concentration 1 &#181;M), 158 &#181;L of 250,000 cells/mL cell density. Example of 10 wells (total volume 2 mL): 400 &#181;L of the biosensor BacMam vector (stock of 2 x 1010 viral genes /mL), 20 &#181;L of trichostatin A (stock of 100 &#181;M), 1,580 &#181;L media with 250,000 cells/mL cell density.</li>
			<li>Add 200 &#181;L of master mix per well. Incubate the cells at 37 &#176;C and 5% CO2 in an incubator for 24 h before running on the plate reading spectrophotometer.</li>
		</ol>
		</li>
	</ol>
	</li>
	<li>Running on a plate reader
	<ol>
		<li>On a benchtop, carefully remove all media in each well and replace with 180 &#181;L of DPBS with Mg2+ and Ca2+ at 37 &#176;C.</li>
		<li>Inspect cells on a microscope to confirm cell health.</li>
		<li>Wrap the plate in aluminum foil and incubate at 37 &#176;C for 30 min-1 h.</li>
		<li>While incubating, prepare the drugs for the reading at 1:10 dilution (also called 10-fold) for the desired final dose. Thus, prepare 100 &#181;M forskolin and 100 nM isoproterenol.</li>
		<li>Add 60 &#181;L of each drug in a columnar fashion to a clear 96-well plate (referred to as the &#34;drug plate&#34;). 
		NOTE: With the proper drug dilution and to optimize the reading, the drugs are added to a clear 96-well plate, referred to as the &#34;drug plate&#34;, to be transferred at the time of the reading to the &#34;tissue plate&#34; using a 96-multi pipettor, allowing the drug to be added to all wells simultaneously and be rapidly read by the fluorescent spectrophotometer.</li>
	</ol>
	</li>
	<li>Fluorescence plate reader setup
	<ol>
		<li>Adjust the settings of the fluorescence plate reader.
		<ol>
			<li>Read Mode: fluorescence. Read Type: kinetic. Wavelengths reading: 494 nm and 522 nm.</li>
			<li>Reading time: Enter 3 min for the baseline fluorescent read and 7 min for the post-drug addition.&#34;Interval&#34; is entered as 00:00:30 for 30 s between each read. 
			NOTE: The reading time can be optimized and increased based on the required time.</li>
		</ol>
		</li>
	</ol>
	</li>
	<li>Data acquisition
	<ol>
		<li>Remove the tissue plate from the incubator, remove the aluminum foil and the plate lid, and place the tissue plate in the plate reader. Close the reader drawer to allow the tissue plate to rest and equilibrate to the reader&#39;s temperature (37 &#176;C).</li>
		<li>Place the clear 96-well plate (drug plate) with the drug dilutions under the 96-multi pipette and practice drawing 20 &#181;L from the wells. Ensure that there is an even volume of drug pulled in the pipettor tips.</li>
		<li>Initiate a &#34;baseline&#34; measurement run. 
		NOTE: 40 RFU or above is considered viable data. If data is below this value, the experiment should be stopped and discarded.</li>
		<li>The tissue plate will eject from the reader at the end of the baseline run. Swiftly and carefully add 20 &#181;L from the clear drug plate to the black tissue plate. Then, quickly begin the &#34;treatment&#34; run. The tissue plate should not be out of the reader for more than 30 s after drugs are added. 
		NOTE: If the drug is added too quickly, the cells detach from the tissue plate, creating an unusable experiment. In addition, the cells are infected with a light-sensitive green fluorescent protein; thus, swiftly and promptly adding the drugs and beginning the second read is imperative to avoid missing the early part of the response.</li>
		<li>Once the second reading is complete, ensure that the tissue plate is ejected from the reader and data collection is concluded. 
		NOTE: Before disposing of the tissue plate, it is best practice to verify that the cells are still attached to the plate. Observe the cells under a microscope. If the cells detach, the results are invalid and should be discarded. The experiment will need to be repeated.</li>
		<li>Export the resulting data as an Excel file.</li>
		<li>Open the exported Excel readable data from the plate reader and copy and paste relevant information into the Excel conversion template. The data will transform from the plate reader set up to single well, column readouts to the right of the copied data. 
		NOTE: Columns of fluorescence for a well over time are listed at RFUs (titled column transformation) and as a decimal change relative to the RFU reading at initial reading (t0 titled Delta F). In the Excel template, the Delta F table is set to the last baseline reading before drug addition. This is the 6th data collection point.</li>
		<li>After data transformation, copy the data from Delta F and paste it into data analysis software as decay or relative decay in fluorescence over time.</li>
		<li>Change the X-title to &#34;time (s)&#34; and the Y-title to &#34;&#916;F/F0&#34; for relative decimal values.</li>
	</ol>
	</li>
</ol>
2. Single-cell assay using an inverted fluorescent microscope
<ol>
	<li>Seeding (HASM) cells with the cADDis BacMam vector in a 35 mm dish (Day 1)
	<ol>
		<li>Split and infect cells in a viral hood.
		<ol>
			<li>Warm HASM media (Table 1), 0.25% trypsin-EDTA in a 37 &#176;C water bath.</li>
			<li>Disinfect the hood and the materials and wipe the hood with EtOH-soaked tissues.</li>
			<li>Remove and discard HASM media from the flask with a serological pipette.</li>
			<li>Add 5 mL of Mg2+ and Ca2+ free DPBS (37 &#176;C) with a new serological pipette and tilt the flask to wash the bottom with the DPBS.</li>
			<li>Trypsinize cells by adding 3 mL of warmed 0.25% trypsin-EDTA with a serological pipette. Tilt the flask to ensure the reagent fully coats the bottom of the flask. Let the reagent sit for 3-5 min to allow the cells to detach from the flask.</li>
			<li>Draw 5 mL of fresh media containing antibiotics and expel the pipette to remove the cells from the bottom of the flask.</li>
			<li>Collect the total volume of the flask (8 mL) centrifuge in a centrifuge tube at 200 x g for 5 min.</li>
			<li>After centrifuging, remove the supernatant with a serological pipette, careful not to disturb the pellet.</li>
			<li>Without disturbing the pellet, add 500 &#181;L of DPBS without Mg2+ and Ca2+ DPBS to the side of the centrifuge tube. Remove and discard as much liquid as possible and repeat one more time. 
			NOTE: This experiment is optimized for a 75 cm2 flask; volume adjustments for reagents may need to be made if a different-size culture apparatus is used.</li>
			<li>Count cells and adjust to 40,000 cells/mL cell density.</li>
			<li>Make a master mix based on the reagent volume needed per well of a 35 mm dish. See volumes below: 
			NOTE: Example of 1 well (total volume 500 &#181;L): 20 &#181;L of the biosensor BacMam vector (stock of 2 x 1010 viral genes /mL), 5 &#181;L trichostatin A (stock of 100 &#181;M, final concentration 1 &#181;M), 500 &#181;L of 40,000 cells/mL cell density. Example for 4 wells (total volume 2 mL): 80 &#181;L of the biosensor BacMam vector (stock of viral genes /mL), 20 &#181;L of trichostatin A (stock of 100 &#181;M, final concentration 1 &#181;M), 2000 &#181;L media 40,000 cells/mL cell density.</li>
			<li>Add 500 &#181;L of master mix per well. Incubate the cells at 37 &#176;C and 5% CO2 for 24 h before continuing the experiment. 
			NOTE: The cell number may vary according to the cell line. To avoid overlapping cells for the analysis, use low cell numbers.</li>
		</ol>
		</li>
	</ol>
	</li>
	<li>Preparing pharmacological agents (Day 2)
	<ol>
		<li>Carefully remove media in each well and replace with 450 &#181;L of DPBS with Mg2+ and Ca2+ at 37 &#176;C.</li>
		<li>Wrap the plate in aluminum foil and incubate the 35 mm disk at 37 &#176;C for 30 min-1 h.</li>
		<li>Inspect cells on a microscope to confirm cell health.</li>
		<li>In the meantime, prepare the drugs for the reading 1 log unit above the desired final concentration (10-fold greater). Thus, prepare 100 &#181;M forskolin and 100 nM isoproterenol.</li>
		<li>For log dose titers, prepare the drug at 10 mM and use serial dilutions to achieve 100 &#181;M of forskolin and 100 nM of isoproterenol.</li>
	</ol>
	</li>
	<li>Data acquisition 
	NOTE: The following settings are for a fluorescent inverted microscope. The software accompanying each microscope can differ; the general settings used in the current protocol are described here.
	<ol>
		<li>Turn on the central hub, then the inverted fluorescent microscope.</li>
		<li>Open the software that will be used for the capture and choose the time-lapse capture option.</li>
		<li>Place a 35 mm dish sample holder in the microscope stage.</li>
		<li>Set objective lens to x20.</li>
		<li>Use autofocus and get as clear a picture as possible. If it is difficult to find individual cells, start on a 4x objective, then move to 20x. Focus the sample manually if the microscope lacks an autofocus feature. 
		NOTE: The magnification of 40x can be used if more significant cell morphological detail is needed.</li>
		<li>Adjust the following settings for obtaining optimal data acquisition: Auto Brightness (exposure), Excitation Wavelength, Black Balance (to reduce background noise), Auto Focus.</li>
		<li>After finding an area of view with several cytoplasmic fluorescing cells, acquire data using time-lapse capture for 20 min every 30 s.</li>
		<li>Click on the go to begin the reading.</li>
		<li>Run for 3 min to collect baseline. As soon as the 3 min capture is taken, gently add 50 &#181;L of the drug to the appropriate well. When the drugs are added, the final concentration on the dish will be 10 &#181;M forskolin and 10 nM of isoproterenol. 
		NOTE: The drug must be added carefully; do not touch the plate with the pipette tip, as this may move the field of view made and make the sample unable to be analyzed.</li>
		<li>Leave the experiment to run for 17 more minutes with data capture every 30 s.</li>
		<li>Once the test is completed, ensure that the data is ready for analysis. 
		NOTE: While the current protocol does not incorporate a control for focal drift, it could be beneficial to include one in the experiment. For instance, the use of nuclear dyes can assist in managing focal drift during microscope analysis, especially when capturing images of live cells over prolonged durations. cADDis biosensors are typically distributed widely within the cell, making a broad focal plane the most effective capture and reducing the need for controlling focal drift9.</li>
	</ol>
	</li>
	<li>Analyzing the data 
	NOTE: The software accompanying each microscope can differ, so the general settings that should be used to analyze the captured images are described here.
	<ol>
		<li>Open the image files captured during the experiment.</li>
		<li>Use the polygon or circle tool to select the region of interest of each cell to perform the analysis. The analysis should give the brightness of each cell at each time point. 
		NOTE: Best practice is to select individual cells and not cells touching the wall of the dish or other cells. This ensures the best data collection possible. Select a minimum of 5 cells for analysis within each condition, and replicate the experiment at least three times.</li>
		<li>After analyzing the data, open the data in an Excel sheet and calculate the average brightness for each condition at each photo, starting at the picture just before adding the pharmacological agents or vehicle. In this example, at the 3 min mark or the 6th photo taken on the microscope, since each picture is taken every 30 s.</li>
		<li>Calculate &#916;F/F0 for each average value in each condition.</li>
		<li>Load into a statistical analysis software and plot &#916;F/F0 against time in s. 
		NOTE: Figure 1 provides a schematic overview of the major steps of the protocols.</li>
	</ol>
	</li>
</ol>

cAMP Analysis with cADDis: Single-Cell to High-Throughput Screening

<ol>
	<li>Krishna, G., Weiss, B., Brodie, B. B. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=A+simple,+sensitive+method+for+the+assay+of+adenyl+cyclase.">A simple, sensitive method for the assay of adenyl cyclase.</a> J Pharmacol Exp Ther. 163 (2), 379-385 (1968).</li><li>Post, S. R., Ostrom, R. S., Insel, P. A. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Biochemical+methods+for+detection+and+measurement+of+cyclic+amp+and+adenylyl+cyclase+activity.">Biochemical methods for detection and measurement of cyclic amp and adenylyl cyclase activity.</a> Methods Mol Biol. 126, 363-374 (2000).</li><li>Li, I. T., Pham, E., Truong, K. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Protein+biosensors+based+on+the+principle+of+fluorescence+resonance+energy+transfer+for+monitoring+cellular+dynamics.">Protein biosensors based on the principle of fluorescence resonance energy transfer for monitoring cellular dynamics.</a> Biotechnol Lett. 28 (24), 1971-1982 (2006).</li><li>Deal, J., Pleshinger, D. J., Johnson, S. C., Leavesley, S. J., Rich, T. C. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Milestones+in+the+development+and+implementation+of+fret-based+sensors+of+intracellular+signals:+A+biological+perspective+of+the+history+of+fret.">Milestones in the development and implementation of fret-based sensors of intracellular signals: A biological perspective of the history of fret.</a> Cell Signal. 75, 109769 (2020).</li><li>Leavesley, S. J., Rich, T. C. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Overcoming+limitations+of+fret+measurements.">Overcoming limitations of fret measurements.</a> Cytometry A. 89 (4), 325-327 (2016).</li><li>Zacharias, D. A., Violin, J. D., Newton, A. C., Tsien, R. Y. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Partitioning+of+lipid-modified+monomeric+GFPS+into+membrane+microdomains+of+live+cells.">Partitioning of lipid-modified monomeric GFPS into membrane microdomains of live cells.</a> Science. 296 (5569), 913-916 (2002).</li><li>Agarwal, S. R., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Compartmentalized+cAMP+signaling+associated+with+lipid+raft+and+non-raft+membrane+domains+in+adult+ventricular+myocytes.">Compartmentalized cAMP signaling associated with lipid raft and non-raft membrane domains in adult ventricular myocytes.</a> Front Pharmacol. 9, 332 (2018).</li><li>Tewson, P. H., Martinka, S., Shaner, N. C., Hughes, T. E., Quinn, A. M. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=New+dag+and+cAMP+sensors+optimized+for+live-cell+assays+in+automated+laboratories.">New dag and cAMP sensors optimized for live-cell assays in automated laboratories.</a> J Biomol Screen. 21 (3), 298-305 (2016).</li><li>Tewson, P., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Assay+for+detecting+Galphai-mediated+decreases+in+cAMP+in+living+cells.">Assay for detecting Galphai-mediated decreases in cAMP in living cells.</a> SLAS Discov. 23 (9), 898-906 (2018).</li><li>Nunez, F. J., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Glucocorticoids+rapidly+activate+cAMP+production+via+g(alphas)+to+initiate+non-genomic+signaling+that+contributes+to+one-third+of+their+canonical+genomic+effects.">Glucocorticoids rapidly activate cAMP production via g(alphas) to initiate non-genomic signaling that contributes to one-third of their canonical genomic effects.</a> FASEB J. 34 (2), 2882-2895 (2020).</li><li>Condreay, J. P., Witherspoon, S. M., Clay, W. C., Kost, T. A. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Transient+and+stable+gene+expression+in+mammalian+cells+transduced+with+a+recombinant+baculovirus+vector.">Transient and stable gene expression in mammalian cells transduced with a recombinant baculovirus vector.</a> Proc Natl Acad Sci U S A. 96 (1), 127-132 (1999).</li><li>Insel, P. A., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=G+protein-coupled+receptor+(GPCR)+expression+in+native+cells:+&amp;#34;Novel&amp;#34;+endogpcrs+as+physiologic+regulators+and+therapeutic+targets.">G protein-coupled receptor (GPCR) expression in native cells: &amp;#34;Novel&amp;#34; endogpcrs as physiologic regulators and therapeutic targets.</a> Mol Pharmacol. 88 (1), 181-187 (2015).</li><li>Nunez, F. J., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Agonist-specific+desensitization+of+PGE(2)-stimulated+cAMP+signaling+due+to+upregulated+phosphodiesterase+expression+in+human+lung+fibroblasts.">Agonist-specific desensitization of PGE(2)-stimulated cAMP signaling due to upregulated phosphodiesterase expression in human lung fibroblasts.</a> Naunyn Schmiedebergs Arch Pharmacol. 393 (2), 843-856 (2020).</li><li>Ojiaku, C. A., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Transforming+growth+factor-beta1+decreases+beta(2)-agonist-induced+relaxation+in+human+airway+smooth+muscle.">Transforming growth factor-beta1 decreases beta(2)-agonist-induced relaxation in human airway smooth muscle.</a> Am J Respir Cell Mol Biol. 61 (2), 209-218 (2019).</li><li>Zuo, H., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Cigarette+smoke+up-regulates+pde3+and+pde4+to+decrease+cAMP+in+airway+cells.">Cigarette smoke up-regulates pde3 and pde4 to decrease cAMP in airway cells.</a> Br J Pharmacol. 175 (14), 2988-3006 (2018).</li><li>Cullum, S. A., Veprintsev, D. B., Hill, S. J. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Kinetic+analysis+of+endogenous+beta(2)+-adrenoceptor-mediated+cAMP+glosensor+responses+in+hek293+cells.">Kinetic analysis of endogenous beta(2) -adrenoceptor-mediated cAMP glosensor responses in hek293 cells.</a> Br J Pharmacol. 180 (2), 1304-1315 (2023).</li><li>Liu, X., Sun, S. Q., Ostrom, R. S. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Fibrotic+lung+fibroblasts+show+blunted+inhibition+by+cAMP+due+to+deficient+cAMP+response+element-binding+protein+phosphorylation.">Fibrotic lung fibroblasts show blunted inhibition by cAMP due to deficient cAMP response element-binding protein phosphorylation.</a> J Pharmacol Exp Ther. 315 (2), 678-687 (2005).</li><li>Bogard, A. S., Birg, A. V., Ostrom, R. S. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Non-raft+adenylyl+cyclase+2+defines+a+cAMP+signaling+compartment+that+selectively+regulates+il-6+expression+in+airway+smooth+muscle+cells:+Differential+regulation+of+gene+expression+by+ac+isoforms.">Non-raft adenylyl cyclase 2 defines a cAMP signaling compartment that selectively regulates il-6 expression in airway smooth muscle cells: Differential regulation of gene expression by ac isoforms.</a> Naunyn Schmiedebergs Arch Pharmacol. 387 (4), 329-339 (2014).</li><li>Schmidt, M., Cattani-Cavalieri, I., Nunez, F. J., Ostrom, R. S. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Phosphodiesterase+isoforms+and+cAMP+compartments+in+the+development+of+new+therapies+for+obstructive+pulmonary+diseases.">Phosphodiesterase isoforms and cAMP compartments in the development of new therapies for obstructive pulmonary diseases.</a> Curr Opin Pharmacol. 51, 34-42 (2020).</li><li>Ostrom, K. F., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Physiological+roles+of+mammalian+transmembrane+adenylyl+cyclase+isoforms.">Physiological roles of mammalian transmembrane adenylyl cyclase isoforms.</a> Physiol Rev. 102 (2), 815-857 (2022).</li><li>Auld, D. S., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Characterization+of+chemical+libraries+for+luciferase+inhibitory+activity.">Characterization of chemical libraries for luciferase inhibitory activity.</a> J Med Chem. 51 (8), 2372-2386 (2008).</li><li>De Logu, F., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Schwann+cell+endosome+CGRP+signals+elicit+periorbital+mechanical+allodynia+in+mice.">Schwann cell endosome CGRP signals elicit periorbital mechanical allodynia in mice.</a> Nat Commun. 13 (1), 646 (2022).</li><li>Wray, N. H., Schappi, J. M., Singh, H., Senese, N. B., Rasenick, M. M. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=NMDAR-independent,+cAMP-dependent+antidepressant+actions+of+ketamine.">NMDAR-independent, cAMP-dependent antidepressant actions of ketamine.</a> Mol Psychiatry. 24 (12), 1833-1843 (2019).</li><li>Thornquist, S. C., Pitsch, M. J., Auth, C. S., Crickmore, M. A. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Biochemical+evidence+accumulates+across+neurons+to+drive+a+network-level+eruption.">Biochemical evidence accumulates across neurons to drive a network-level eruption.</a> Mol Cell. 81 (4), 675-690 (2021).</li><li>Zhang, S. X., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Hypothalamic+dopamine+neurons+motivate+mating+through+persistent+cAMP+signalling.">Hypothalamic dopamine neurons motivate mating through persistent cAMP signalling.</a> Nature. 597 (7875), 245-249 (2021).</li><li>Lutas, A., Fernando, K., Zhang, S. X., Sambangi, A., Andermann, M. L. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=History-dependent+dopamine+release+increases+cAMP+levels+in+most+basal+amygdala+glutamatergic+neurons+to+control+learning.">History-dependent dopamine release increases cAMP levels in most basal amygdala glutamatergic neurons to control learning.</a> Cell Rep. 38 (4), 110297 (2022).</li><li>Zhang, C., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Area+postrema+cell+types+that+mediate+nausea-associated+behaviors.">Area postrema cell types that mediate nausea-associated behaviors.</a> Neuron. 109 (3), 461-472 (2021).</li></ol>

The authors have no competing financial interests.

Accurate and sensitive measurement of cAMP is crucial for understanding its role in various cellular processes and for studying the activity of cAMP-dependent signaling pathways. There are several methods commonly employed to measure cAMP levels, including ELISA, radioimmunoassay, FRET biosensors, and the GloSensor cAMP assay14,15,16,17,18. Each cAMP assay has...

Adenosine 3&#8242;,5&#8242;-cyclic monophosphate, cAMP, plays a central role in cellular communication and the coordination of various physiological processes. cAMP acts as a second messenger, relaying external signals from hormones, neurotransmitters, or other extracellular molecules to initiate a cascade of intracellular events1. Moreover, cAMP is intricately involved in various signaling pathways, including those associated with G-protein-coupled receptors (GPCRs) and adenylyl cyclases. Understanding the role of cAMP in cellular signaling is fundamental to unraveling the complex mechanisms that underlie normal cellular functions and the development of potential therapies for a wide range of medical conditions2.
In the past, various methods have been employed to measure cAMP directly or indirectly. These included radiolabeling of cellular ATP pools followed by column purification, HPLC, radioimmunoassays, and enzyme-linked immunoassays1,2. These legacy assays are limited by the fact that they are end-point measures, requiring a large number of samples to construct time-dependent responses. More recently, Fluorescence Resonance Energy Transfer (FRET) sensors were developed to create assays in living cells, producing real-time, dynamic data and allowing sensors to be targeted in different subcellular locations3. FRET leverages two fluorophores, one fluorescent donor, and one fluorescent acceptor that when in close proximity, the acceptor fluorophore will be excited by the donor fluorescent output. The two fluorophores most used are cyan fluorescent protein (CFP) and yellow fluorescent protein (YFP) since these have compatible excitation and emission properties. In addition to CFP and YFP, the utilization of the green fluorescent protein (GFP) and red fluorescent protein (RFP) is commonly used for FRET biosensors. cAMP FRET biosensors operate by having a donor and acceptor on opposite ends of the Epac2 cAMP binding protein. cAMP binding alters the confirmation of Epac and increases the distance between donor and acceptor fluorophores3,4. This conformational change is detected by a loss of FRET, that is, the excitation of the acceptor fluorophore by energy transferred from the donor fluorophore drops3. While a seemingly simple process, there are an abundance of limitations and issues with the FRET biosensor for cAMP research5. One of which is the selection of fluorescent proteins, for example, GFP, which can dimerize naturally, thus reducing sensitivity6. FRET-based cAMP biosensors have been targeted to specific microdomains7, but there may be limitations owing to the large size of a construct with two fluorophores6. Another significant issue is the low signal-to-noise ratio of FRET signals resulting from the overlap between excitation and emission of the fluorophore, resulting in high sampling frequency and complicating analysis of the results4,5.
Most recently, the novel biosensor (cAMP Difference Detector In Situ), cADDis has solved these and other limitations when it comes to studying the regulation of cAMP signaling8. One important improvement is the dependence on a single fluorophore. This allows for a rapid and efficient signal with a wider dynamic range and a high signal-to-noise ratio. As a result, there can be more accuracy as there is a less broad scope of wavelengths to comb through8. Like FRET probes, the biosensor has been targeted to subcellular locations, allowing research into the compartmentation theory and exploration in lipid rafts and non-rafts, and other subcellular domains9. Perhaps most important is the suitability of a single fluorophore biosensor for high-throughput screening, which has improved sensitivity and reproducibility over FRET-based biosensors. The biosensor is packaged into a BacMam vector for easy transduction of a wide array of cell types and precise control over protein expression.
Expression control via the BacMam vector can be particularly useful in assays using GPCR orthologs from different species to facilitate the interpretation of data from animal studies. Furthermore, control over receptor expression is critical for measuring the different degrees of drug efficacy (e.g., inverse agonists and partial agonists), and low levels of receptor expression are useful to mimic the low levels found in animal tissue. BacMam is a baculovirus vector that has been modified to transduce mammalian cells such as primary cell cultures and HEK-293 lines10. Dominant selectable markers allow for BacMam to provide more stability over traditional plasmid infections11. Such selective promoters allow for more efficient gene delivery and expression. In addition, adding trichostatin A (a histone deacetylase inhibitor) enhances the reporter protein levels11. Expression levels can be controlled via the titer of the BacMam virus used and should be optimized for each cell type. In the case of this biosensor, a red or green fluorescent protein is linked to the Epac at the N- and C-termini. When cAMP binds, a conformational change in the biosensor moves amino acids adjacent to the fluorescent protein. Such a shift moves the absorbance from the anionic state to the neutral state at 400 nm, thus decreasing the fluorescence.
There are 90-120 GPCRs expressed in a single cell that respond to a wide variety of neurohumoral signals12. Therefore, it can be hypothesized that at least several dozen GPCRs per cell can stimulate or inhibit cAMP through Gs or Gi coupling, respectively. While there has been progress in monitoring this second messenger in real-time, such as FRET, more efficient methods are needed. The methodology for monitoring the synthesis and degradation of cAMP signals using cADDis in real-time is presented here. The change in fluorescence can be monitored in real-time using a fluorescence plate reader for high throughput assays or using a fluorescent microscope for single-cell assays. These methods are useful for a wide array of biological questions regarding GPCR signaling via cAMP.

<table border="1" fo:keep-together.within-page="1" fo:keep-with-next.within-page="always">
	<tbody>
		<tr>
			<td>96-well plate (clear)</td>
			<td>Fisherbrand</td>
			<td>21-377-203</td>
			<td></td>
		</tr>
		<tr>
			<td>35 mm dish</td>
			<td>Greiner Bio-One</td>
			<td>627870</td>
			<td>Cell culture dishes with glass bottom</td>
		</tr>
		<tr>
			<td>96-well plate&#160;</td>
			<td>Corning</td>
			<td>3904</td>
			<td>Black with clear flat bottom</td>
		</tr>
		<tr>
			<td>Antibiotic-Antimycotic (100x)</td>
			<td>Gibco</td>
			<td>15240062</td>
			<td>For HEK and HASM media</td>
		</tr>
		<tr>
			<td>BZ-X fluorescence microscope</td>
			<td>Keyence</td>
			<td></td>
			<td></td>
		</tr>
		<tr>
			<td>Calcium chloride (IM)</td>
			<td>Quality Biological Inc</td>
			<td>E506</td>
			<td>For HASM media</td>
		</tr>
		<tr>
			<td>Centrifuge tube (15 mL)</td>
			<td>Thermo Scientific</td>
			<td>339651</td>
			<td></td>
		</tr>
		<tr>
			<td>DMEM (1x)</td>
			<td>Gibco</td>
			<td>11965092</td>
			<td>HEK media</td>
		</tr>
		<tr>
			<td>DPBS with Mg2+ and Ca2+&#160;</td>
			<td>Gibco</td>
			<td>14040-133</td>
			<td></td>
		</tr>
		<tr>
			<td>DPBS without Mg2+ and Ca2+</td>
			<td>Corning</td>
			<td>14040-133</td>
			<td></td>
		</tr>
		<tr>
			<td>Fetal Bovine Serum (FBS)</td>
			<td>R&#38;D systems</td>
			<td>S11195</td>
			<td>For HEK and HASM media</td>
		</tr>
		<tr>
			<td>Forskolin</td>
			<td>Millipore</td>
			<td>344270</td>
			<td>Drug</td>
		</tr>
		<tr>
			<td>Green Down cADDis cAMP Assay Kit</td>
			<td>Montana Molecular</td>
			<td>#D0200G</td>
			<td>Reagent</td>
		</tr>
		<tr>
			<td>Ham&#39;s F-12K&#160;</td>
			<td>Gibco</td>
			<td>21127022</td>
			<td>For HASM media</td>
		</tr>
		<tr>
			<td>HEPES (1M)</td>
			<td>Gibco</td>
			<td>15630080</td>
			<td>For HASM media</td>
		</tr>
		<tr>
			<td>Isoproterenol</td>
			<td>Sigma</td>
			<td>I6504</td>
			<td>Drug</td>
		</tr>
		<tr>
			<td>L-glutamine 200 mM (100x)</td>
			<td>Gibco</td>
			<td>25030-081</td>
			<td>For HASM media</td>
		</tr>
		<tr>
			<td>Microcentrifuge tube (2 mL)</td>
			<td>Eppendorf</td>
			<td>22363352</td>
			<td></td>
		</tr>
		<tr>
			<td>Primocin</td>
			<td>Invitrogen</td>
			<td>ant-pm-1</td>
			<td>Antibiotic for HASM media</td>
		</tr>
		<tr>
			<td>RNAse away</td>
			<td>Thermo Scientific</td>
			<td>700511</td>
			<td>Reagent</td>
		</tr>
		<tr>
			<td>Sodium hydroxide solution</td>
			<td>Sigma</td>
			<td>S2770</td>
			<td>For HASM media</td>
		</tr>
		<tr>
			<td>Spectrmax M5 plate reader</td>
			<td>Molecular Devices</td>
			<td></td>
			<td></td>
		</tr>
		<tr>
			<td>Trichostatin A</td>
			<td>TCI America</td>
			<td>T2477</td>
			<td>Reagent</td>
		</tr>
		<tr>
			<td>Trypsin EDTA</td>
			<td>Gibco</td>
			<td>25200-056</td>
			<td>Reagent</td>
		</tr>
	</tbody>
</table>

real-time camp dynamics in live cells using the fluorescent camp difference detector in situ

cAMP Difference Detector In Situ (cADDis) is a novel biosensor that allows for the continuous measurement of cAMP levels in living cells. The biosensor is created from a circularly permuted fluorescent protein linked to the hinge region of Epac2. This creates a single fluorophore biosensor that displays either increased or decreased fluorescence upon binding of cAMP. The biosensor exists in red and green upward versions, as well as green downward versions, and several red and green versions targeted to subcellular locations. To illustrate the effectiveness of the biosensor, the green downward version, which decreases in fluorescence upon cAMP binding, was used. Two protocols using this sensor are demonstrated: one utilizing a 96-well plate reading spectrophotometer&#160;compatible with high-throughput screening and another utilizing single-cell imaging on a fluorescent microscope. On the plate reader, HEK-293 cells cultured in 96-well plates were stimulated with 10 &#181;M forskolin or 10 nM isoproterenol, which induced rapid and large decreases in fluorescence in the green downward version. The biosensor was used to measure cAMP levels in individual human airway smooth muscle (HASM) cells monitored under a fluorescent microscope. The green downward biosensor displayed similar responses to populations of cells when stimulated with forskolin or isoproterenol. This single-cell assay allows visualization of the biosensor location at 20x and 40x magnification. Thus, this cAMP biosensor is sensitive and flexible, allowing real-time measurement of cAMP in both immortalized and primary cells, and with single cells or populations of cells. These attributes make cADDis a valuable tool for studying cAMP signaling dynamics in living cells.

Author Spotlight: Advancing Real-Time cAMP Detection in Cells Using cADDis Biosensor

Real-Time cAMP Dynamics in Live Cells Using the Fluorescent cAMP Difference Detector In Situ

We serve the organization of cycling KP micro domains with a focus on elucidating how these compartments are formed and sustained. We seek to uncover the key components that enable cells to discern spatial signals within these domains, exploring variation in their interpretation, and how these features are altered in diseases like asthma and COPD. Infecting primary cells using the Beckman vector is challenging.For this, the condition should be optimized for individual cells type in order to achieve sufficient expression of the biosensor. This protocol allows the real time detection and monitoring, ranging from minutes to hours, and measurement of cyclo campu dynamics within living cells. This biosensor has high specificity for abiding to cyclo camp P.Consequently, the signals generated by this essay directly correlates to cyclic P levels, significantly reducing the potential interference from the other cellular components, and providing reliable results.

The present study validated the cytosolic biosensor in both plate reader and microscope assays. Once cells expressed the biosensor, they were stimulated with either 10 &#181;M forskolin (a direct activator of adenylyl cyclase), 10 nM isoproterenol (an agonist at &#223;1AR and &#223;2AR), or vehicle (Figure 1). The subsequent changes in fluorescence, indicative of cAMP production, were captured every 30 s.
The data was transformed as the chang...

Read this Scientific Article Protocol about Author Spotlight: Advancing Real-Time cAMP Detection in Cells Using cADDis Biosensor at JoVE.com

The protocol presented in this study illustrates the effectiveness of the cAMP Difference Detector In Situ in measuring cAMP through two methods. One method utilizes a 96-well plate reading spectrophotometer with HEK-293 cells. The other method demonstrates individual HASM cells under a fluorescent microscope.

cAMP Difference Detector In Situ (cADDis) is a novel biosensor that allows for the continuous measurement of cAMP levels in living cells. The biosensor is ...

real-time-camp-dynamics-live-cells-using-fluorescent-camp-difference

Research

JoVE Journal

Biochemistry

Preparing HASM Cells for cAMP Detection Using Inverted Fluorescence Microscopy

Inverted Fluorescence Microscopy and Data Analysis to Assess Drug Effects on cAMP in HASM Cells

563 Views.  Chapman University School of Pharmacy.  The protocol presented in this study illustrates the effectiveness of the cAMP Difference Detector In Situ  in measuring cAMP through two methods. One method utilizes a 96-well plate reading spectrophotometer with HEK-293 cells. The other method demonstrates individual HASM cells under a fluorescent microscope.

cAMP Analysis with cADDis: Single-Cell to High-Throughput Screening

Summary